Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–iv40.

Article  CAS  PubMed  Google Scholar 

Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Kolorektales Karzinom. Langversion ed. Vol. 2.1. 2019. AWMF Registrierungsnummer: 021/007OL2019.

Google Scholar 

Österreichische Gesellschaft für Chirurgische Onkologie, der Chirurgischen Krebstherapie M. Krause & Pachernegg GmbH. WIRTSCHAFT: VERLAG für MEDIZIN und; 2011. p. 356.

Google Scholar 

Body A, Prenen H, Lam M, Davies A, Tipping-Smith S, Lum C, et al. Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges. Clin Colorectal Cancer. 2021;20(1):29–41.

Article  PubMed  Google Scholar 

Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42.

Article  CAS  PubMed  Google Scholar 

Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702–15.

Article  CAS  PubMed  Google Scholar 

Habr-Gama A, Perez RO. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg. 2009;96(2):125–7.

Article  CAS  PubMed  Google Scholar 

Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol.2022:JCO2200032.

Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres. Eur J Surg Oncol. 2017;43(1:107–17.

Article  Google Scholar 

Heald RJ. The ‘Holy Plane’ of rectal surgery. J R Soc Med. 1988;81(9):503–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marco S. Referenz Allgemein- und Viszeralchirurgie – Unterer Gastrointestinaltrakt. 2022.

Google Scholar 

Holmer C. Sphinktererhaltende Operationen beim Rektumkarzinom. In: Kreis ME, Asbach P, editors. MRT-basierte Chirurgie des Rektumkarzinoms. Berlin, Heidelberg: Springer Berlin Heidelberg; 2020. pp. 109–14.

Chapter  Google Scholar 

Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251(5):807–18.

Article  PubMed  Google Scholar 

Kienle P, Magdeburg JR. Chronic anastomotic leak after low rectal resection—an unsolved problem? Chirurg. 2021;92(7):605–11.

Article  PubMed  Google Scholar 

Wu SW, Ma CC, Yang Y. Role of protective stoma in low anterior resection for rectal cancer: a meta-analysis. World J Gastroenterol. 2014;20(47):18031–7.

Article  PubMed  PubMed Central  Google Scholar 

Sharp G, Steffens D, Koh CE. Evidence of negative pressure therapy for anastomotic leak: a systematic review. ANZ J Surg. 2021;91(4):537–45.

Article  PubMed  Google Scholar 

Kreis M, Straßburg J. Moderne Chirurgie des Rektumkarzinoms. Veralg: Springer; 2015.

Book  Google Scholar 

Keane C, Fearnhead NS, Bordeianou LG, Christensen P, Basany EE, Laurberg S, et al. International Consensus Definition of Low Anterior Resection Syndrome. Dis Colon Rectum. 2020;63(3):274–84.

Article  PubMed  PubMed Central  Google Scholar 

Emmertsen KJ, Laurberg S, Group RCFS.. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013;100(10):1377–87.

Article  CAS  PubMed  Google Scholar 

Erlandsson J, Lörinc E, Ahlberg M, Pettersson D, Holm T, Glimelius B, et al. Tumor regression after radiotherapy for rectal cancer—Results from the randomised Stockholm III trial. Radiother Oncol. 2019;135:178–86.

Article  PubMed  Google Scholar 

van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–45.

Article  PubMed  Google Scholar